NCI chief says no retreat from fundamental research

Nature News has an in-depth, Q&A interview with Harold Varmus, chief of the National Cancer Institute. He bemoans the decline in funding, saying it has "...slowed the progress that is so important to the public, caused a lot of distress in our scientific community..." Still, he says, there's a great deal that can be done with a $5 billion budget. One thing that should be done, Varmus says, is to delve deeper into a basic understanding of genetic changes in cancer cells and how to use that fundamental information to fight it. "All basic scientists who look to the NCI for funding should know that I will tolerate no retreat on the study of model systems and the pursuit of fundamental biological principles." Interview

Suggested Articles

Compass' CD137 agonist cleared large tumors in mice that other I-O agents had failed to treat. It's advancing the drug into phase 1 human trials.

UPMC researchers are planning clinical trials of a COVID-19 vaccine that uses pieces of the virus' spike protein to create immunity.

Treating mice with niacin increased the number of immune cells in glioblastomas, reducing tumor size and extending survival.